Assessment of eosinophilic nasal inflammation in patients with severe asthma and nasal polyposis before and after six months of therapy with Benralizumab

被引：1
|
作者：
Buonamico, E. [1 ]
Dragonieri, S. [1 ]
Sciancalepore, P. I. [2 ]
Carratu, P. [1 ]
Carpagnano, G. E. [1 ]
Resta, O. [1 ]
Gelardi, M. [3 ]
机构：
[1] Univ Bari, Resp Dis, Bari, Italy
[2] Univ Bari, Otolaringol, Bari, Italy
[3] Univ Foggia, Otolaringol, Foggia, Italy
来源：
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS | 2020年 / 34卷 / 06期
关键词：
nasal citology; eosinophils; severe asthma; nasal polyposis; Benralizumab; RHINOSINUSITIS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2353 / 2357
页数：5
相关论文
共 50 条
  • [31] Effects of Fluticasone Furoate Nasal Spray on Parameters of Eosinophilic Inflammation in Patients With Nasal Polyposis and Perennial Allergic Rhinitis
    Mirkovic, Cveta Spadijer
    Peric, Aleksandar
    Durdevic, Biserka Vukomanovic
    Vojvodic, Danilo
    [J]. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2017, 126 (08): : 573 - 580
  • [32] Real-Life Clinical Outcomes of Benralizumab Treatment in Patients with Uncontrolled Severe Asthma and Coexisting Chronic Rhinosinusitis with Nasal Polyposis
    Chiner, Eusebi
    Murcia, Maria
    Boira, Ignacio
    Bernabeu, Maria Angeles
    Esteban, Violeta
    Martinez-Moragon, Eva
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (14)
  • [33] Exacerbation Reduction and Early and Sustained Improvements in SGRQ, Lung Function, and Symptoms of Nasal Polyposis with Benralizumab for Severe, Eosinophilic Asthma: Phase IIIb ANDHI Trial
    Harrison, T. W.
    Chanez, P.
    Menzella, F.
    Canonica, G. W.
    Louis, R.
    Cosio, B. G.
    Lugogo, N. L.
    Mohan, A.
    Burden, A.
    McDermott, L.
    Garcia Gil, E.
    Zangrilli, J. G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [34] Association between nasal polyposis and T2 airway inflammation in severe asthma
    Tudorache, E.
    Vastag, Z.
    Suppini, N.
    Oancea, C.
    Fira-Mladinescu, O.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [35] Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis
    D'Amato, Maria
    Menzella, Francesco
    Altieri, Elena
    Bargagli, Elena
    Bracciale, Pietro
    Brussino, Luisa
    Caiaffa, Maria Filomena
    Canonica, Giorgio Walter
    Caruso, Cristiano
    Centanni, Stefano
    De Michele, Fausto
    Di Marco, Fabiano
    Pastorello, Elide Anna
    Pelaia, Girolamo
    Rogliani, Paola
    Romagnoli, Micaela
    Schino, Pietro
    Senna, Gianenrico
    Vultaggio, Alessandra
    Ori, Alessandra
    Simoni, Lucia
    Boarino, Silvia
    Vitiello, Gianfranco
    Aliani, Maria
    Del Giacco, Stefano
    [J]. FRONTIERS IN ALLERGY, 2022, 3
  • [36] Serum interleukin-5 and eosinophilic leucocytes in patients with bronchial asthma and nasal polyposis
    Bogic, M
    Savic, N
    Jovicic, Z
    Colic, M
    Tomic-Spiric, V
    Raskovic, S
    [J]. ALLERGY, 2002, 57 : 326 - 327
  • [37] Early response and remission with benralizumab in patients with severe asthma and chronic rhinosinusitis with nasal polyposis ( CRSwNP) in the prospective real-world imPROve Asthma study
    Korn, S.
    Watz, H.
    Emmanuel, B.
    Plate, T.
    Saathoff, M.
    Shavit, A.
    Grund, T.
    Lommatzsch, M.
    [J]. PNEUMOLOGIE, 2023, 77 : S76 - S76
  • [38] Early response and remission with benralizumab in patients with severe asthma and chronic rhinosinusitis with nasal polyposis (CRSwNP) in the prospective real-world ImPROve Asthma study
    Korn, S.
    Watz, H.
    Emmanuel, B.
    Plate, T.
    Saathoff, M.
    Shavit, A.
    Grund, T.
    Lommatzsch, M.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [39] Facial pain/headache before and after surgery in patients with nasal polyposis
    Duc Trung Nguyen
    Felix-Ravelo, Marylisa
    Arous, Fabien
    Phi-Linh Nguyen-Thi
    Jankowski, Roger
    [J]. ACTA OTO-LARYNGOLOGICA, 2015, 135 (10) : 1045 - 1050
  • [40] Benralizumab continues to improve quality of life after 6 months of treatment in Canadians with severe eosinophilic asthma
    Penz, E.
    Kayaniyil, S.
    Lancaster, B.
    Francoeur, B.
    Lee, J. K.
    Mallet, M.
    Tourin, O.
    Ramesh, W.
    Mahdavian, M.
    Walker, B. L.
    Belak, Z.
    Thawer, A.
    Dhawan, V
    Mbuagbaw, L.
    Noorduyn, S. G.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
12345